GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bionovate Technologies BIIO · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

-99.00%

Close of 2 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2021

Revenue

—

FY2014FY2021

Net income

−$106,544

FY2014FY2021

Free cash flow

—

FY2014FY2021

Shareholders' equity

−$503,209

FY2014FY2021

Income statement

Fiscal years

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue————$5,386$6,118$4,435$8,249
Operating income−$45,371−$33,055−$56,543−$118,877−$87,734−$38,361−$48,204−$91,205
Net income−$106,544−$122,045−$208,896−$1.7m−$323,313−$38,361−$48,204−$91,205
Diluted earnings per share-0.01-0.00-1.34-11.17-107.99-11.91-14.96—

Balance sheet

At each fiscal year end

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets—————$936$617$967
Total liabilities$503,209$396,665$332,289$309,682$229,148$151,571$116,938$83,882
Debt——$183,668—————
Shareholders' equity−$503,209−$396,665−$332,289−$309,682−$229,148−$150,635−$116,321−$82,915
Shares outstanding8m59m0m0m0m0m0m—

Cash flow

Fiscal years

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations————$10,604$429−$311−$56,353
Free cash flow————$10,604$429−$311−$56,353

Latest quarters

By quarter end

Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020Dec 2019
Operating income−$6,279−$4,376−$16,685−$20,688−$3,622−$5,945−$2,748−$10,950
Net income−$21,636−$19,571−$31,665−$32,434−$22,874−$22,962−$24,138−$45,569
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.29
Debt———————$203,128
Shareholders' equity−$524,845−$503,209−$483,638−$451,973−$419,539−$396,665−$375,703−$387,816

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-27.5%3.4%—
Net income-60.6%22.7%—

Valuation history

At each fiscal year end

FY2021FY2020FY2014
Price to earnings-10.9-41.9—
Price to sales——0.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%0%-100%268%38884%-86%553%-90%12251%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-to-1 reverse split · 9 Jan 2020
  • 50-to-1 reverse split · 21 Dec 2017

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.